Connect with us

Hi, what are you looking for?

Sports

New York Mets pitcher to miss rest of season after Achilles surgery

New York Mets pitcher Griffin Canning was placed on the 60-day injury list on Friday and is expected to miss the rest of the 2025MLB season after rupturing his left Achilles tendon on Thursday, June 26.

Canning had surgery to repair the tendon and the recovery process may cause Canning to miss the 2026 season.

Canning is the third pitcher on the Mets’ Opening Day rotation to get hurt in the past two weeks. Kodai Senga was placed on the injured list after suffering a right hamstring strain on June 12, while Tylor Megill hasn’t pitched since June 14 because of a right elbow sprain. The Mets have gone just 4-10 since those injuries.

Meanwhile, left-hander Sean Manaea, who seemed close to returning from an oblique injury suffered in spring training, was diagnosed with a bone chip in his elbow after his most recent rehab appearance in Syracuse (AAA).

How did Griffin Canning’s injury occur?

Canning was injured while coming off the mound to field a ground ball during the 4-0 victory over the Atlanta Braves on Thursday.

Griffin Canning’s contract

The 29-year-old signed a one-year contract worth $4.25 million as a free agent during the offseason.

Griffin Canning’s stats

He was 7-3 with a 3.77 ERA in 16 starts this season.  Canning has pitched 76.1 innings this season.

He spent the first six years of his career with the Los Angeles Angels but did not play in 2022 due to injury. He went 25-34 in 94 starts for the Angels with a 4.78 ERA.

This post appeared first on USA TODAY

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    You May Also Like

    Politics

    With President Donald Trump’s extraordinary decision to attack three of the key/critical Iranian nuclear sites, two questions emerge: First, how will the Iranian populace...

    Stocks

    The stock market has been on quite the rollercoaster of late, thanks to news headlines. But investors seem to have shrugged off the past...

    Stocks

    Join Dave as he shares how he uses the power of Fibonacci retracements to anticipate potential turning points. He takes viewers through the process...

    Politics

    It’s a measure of President Trump’s success in bombing Iran’s key nuclear sites that even some of his harshest detractors are praising the risky...

    Disclaimer: plannprofit.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 plannprofit.com | All Rights Reserved